Wire Stories
-
587Myanmar Crawler Excavator Market Report 2021: Strategic Assessment & Forecasts to 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Myanmar Crawler Excavator Market – Strategic Assessment & Forecast 2021-2027” report has been added to ResearchAndMarkets.com’s offering. Myanmar crawler excavator...
-
611
Montr�al Exchange Extends Trading Hours to Asia Pacific Time Zones
Canada�s Derivatives Exchange further expands global reach, syncing trading hours with Asia Pacific markets in support of growing investor demand MONTR�AL–(BUSINESS WIRE)–Montr�al...
-
706
Fusionex Signs MoU with Alliance Islamic Bank to Accelerate SMEs� Halal Business Growth
PETALING JAYA, Malaysia–(BUSINESS WIRE)–#AllianceIslamicBank–Artificial Intelligence and Big Data technology market leader Fusionex recently signed an MoU with Alliance Islamic Bank Berhad to...
-
880
Rio Tinto to triple Weipa solar capacity and add battery storage to help power operations
MELBOURNE, Australia–(BUSINESS WIRE)–Rio Tinto has approved a new solar farm and battery storage at Weipa in Queensland, in a move that will...
-
815
Datopotamab Deruxtecan Shows Encouraging Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations
Sub-analysis of TROPION-PanTumor01 phase 1 trial of datopotamab deruxtecan featured as late-breaking Mini Oral presentation at ESMO TROPION-Lung05 phase 2 trial currently...
-
661
�Celltrion�s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
�The approval marks the first time a monoclonal antibody treatment for COVID-19 received full approval to treat patients with COVID-19 The approval...
-
613
ENHERTU� Demonstrated Robust and Durable Tumor Response of 54.9% in Patients with HER2 Mutant Metastatic Non-Small Cell Lung Cancer
First HER2 directed therapy to show a strong tumor response in this population Data from HER2 mutant cohort of pivotal DESTINY-Lung01 phase...
-
635
Enfusion Files Registration Statement with SEC for Proposed Initial Public Offering
NEW YORK & LONDON & HONG KONG–(BUSINESS WIRE)–Enfusion, Inc. (“Enfusion”), a leading provider of cloud-based investment management software and services, today announced...
-
566
Metals Acquisition Corp. Announces the Separate Trading of its Shares of Class A Ordinary Shares and Redeemable Warrants Commencing September 20, 2021
FORT WORTH, Texas–(BUSINESS WIRE)–Metals Acquisition Corp. (NYSE: MTAL.U) (the �Company�) announced that, commencing September 20, 2021, holders of the units sold in...
-
738
ENHERTU� Demonstrated Clinically Meaningful and Durable Response in Patients with HER2 Positive Advanced Gastric Cancer in DESTINY-Gastric02 Phase 2 Trial
First ENHERTU trial in Western patients with gastric cancer Efficacy and safety results consistent with pivotal DESTINY-Gastric01 trial; will support ongoing discussions...
